{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T09:40:31Z","timestamp":1649756431410},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Bonn"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00347-021-01355-y","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T15:02:59Z","timestamp":1615388579000},"page":"400-402","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["\u201eAkuter\u201c Keratokonus?"],"prefix":"10.1007","volume":"119","author":[{"given":"Marlene","family":"Sa\u00dfmannshausen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina C.","family":"Herwig-Carl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank G.","family":"Holz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin U.","family":"Loeffler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,10]]},"reference":[{"issue":"4","key":"1355_CR1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S1350-9462(98)00033-0","volume":"18","author":"ME Fini","year":"1999","unstructured":"Fini\u00a0ME (1999) Keratocyte and fibroblast phenotypes in the repairing cornea. Prog Retin Eye Res 18(4):529\u2013551","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"1355_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ophtha.2013.09.014","volume":"121","author":"C Jordan","year":"2014","unstructured":"Jordan\u00a0C, Patel\u00a0DV, Abeysekera\u00a0N, McGhee\u00a0CNJ (2014) In vivo confocal microscopy analyses of corneal microstructural changes in a\u00a0prospective study of collagen cross-linking in keratoconus. Ophthalmology 121(2):469\u2013474","journal-title":"Ophthalmology"},{"issue":"10","key":"1355_CR3","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/j.biocel.2006.03.010","volume":"38","author":"JA West-Mays","year":"2006","unstructured":"West-Mays\u00a0JA, Dwivedi\u00a0DJ (2006) The keratocyte: corneal stromal cell with variable repair phenotypes. Int J Biochem Cell Biol 38(10):1625\u20131631","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"1355_CR4","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/ICO.0b013e318030df5a","volume":"26","author":"C Mazzotta","year":"2007","unstructured":"Mazzotta\u00a0C, Balestrazzi\u00a0A, Traversi\u00a0C, Baiocchi\u00a0S, Caporossi\u00a0T, Tommasi\u00a0C, Caporossi\u00a0A (2007) Treatment of progressive keratoconus by riboflavin-UVA-induced cross-linking of corneal collagen: ultrastructural analysis by Heidelberg retinal tomograph II in vivo confocal microscopy in humans. Cornea 26(4):390\u2013397","journal-title":"Cornea"},{"issue":"2","key":"1355_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/ICO.0b013e31824d701b","volume":"32","author":"EM Messmer","year":"2013","unstructured":"Messmer\u00a0EM, Meyer\u00a0P, Herwig\u00a0MC, Loeffler\u00a0KU, Schirra\u00a0F, Seitz\u00a0B, Thiel\u00a0M, Reinhard\u00a0T, Kampik\u00a0A, Auw-Haedrich\u00a0C (2013) Morphological and immunohistochemical changes after corneal cross-linking. Cornea 32(2):111\u2013117","journal-title":"Cornea"},{"issue":"7","key":"1355_CR6","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1055\/s-0043-102577","volume":"235","author":"PL M\u00fcller","year":"2018","unstructured":"M\u00fcller\u00a0PL, L\u00f6ffler\u00a0KU, Kohlhaas\u00a0M, Holz\u00a0FG, Herwig-Carl\u00a0MC (2018) Morphologische Hornhautver\u00e4nderungen nach Crosslinking bei Keratokonus. Klin Monbl Augenheilkd 235(7):809\u2013819","journal-title":"Klin Monbl Augenheilkd"},{"issue":"3","key":"1355_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/ICO.0000000000002144","volume":"39","author":"PL M\u00fcller","year":"2020","unstructured":"M\u00fcller\u00a0PL, Loeffler\u00a0KU, Messmer\u00a0E, Holz\u00a0FG, Perdikakis\u00a0G, Kohlhaas\u00a0M, Herwig-Carl\u00a0MC (2020) Histological corneal alterations in keratoconus after crosslinking-expansion of findings. Cornea 39(3):333\u2013341","journal-title":"Cornea"},{"issue":"2","key":"1355_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/ICO.0b013e3182553aac","volume":"32","author":"I Pecorella","year":"2013","unstructured":"Pecorella\u00a0I, Appolloni\u00a0R, Tiezzi\u00a0A, Plateroti\u00a0P, Plateroti\u00a0R (2013) Histological findings in a\u00a0failed corneal riboflavin\u2014UVA collagen cross-linking performed for progressive keratoconus. Cornea 32(2):191\u2013195","journal-title":"Cornea"},{"issue":"10","key":"1355_CR9","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1055\/s-0043-111797","volume":"235","author":"F Raiskup","year":"2018","unstructured":"Raiskup\u00a0F, Lenk\u00a0J, Herber\u00a0R, Gatzioufas\u00a0Z, Sp\u00f6rl\u00a0E (2018) Therapeutic options in keratoconus. Klin Monbl Augenheilkd 235(10):1148\u20131158","journal-title":"Klin Monbl Augenheilkd"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-021-01355-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-021-01355-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-021-01355-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T09:07:14Z","timestamp":1649754434000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-021-01355-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,10]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1355"],"URL":"https:\/\/doi.org\/10.1007\/s00347-021-01355-y","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,10]]},"assertion":[{"value":"1 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.C.\u00a0Herwig-Carl: Forschungsf\u00f6rderung durch EPIC-XS. F.G.\u00a0Holz: Forschungsf\u00f6rderung und Beratung von Genentech\/Roche, Bayer, Boehringer Ingelheim, Novartis, Allergan, Heidelberg Engineering; Beratung von Apellis, Lin BioScience; Forschungsf\u00f6rderung von Nightstar, CenterVue, Optos, Acucela, Alcon; Advisory Boards: Acucela, Allergan, Avalanche, Bayer, Genentech, Heidelberg Engineering, Johnson & Johnson, Lin BioScience, Novartis, Ophthotech, Roche, Oxurion. M.\u00a0Sa\u00dfmannshausen und K.U.\u00a0Loeffler geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}